Literature DB >> 3799741

Screening for postmenopausal osteoporosis.

M R Davis.   

Abstract

Postmenopausal osteoporosis is an area of increasing concern to the gynecologist. Fractures will develop in approximately 15% to 25% of women in their later years and preventive therapy is best aimed specifically at this group. Predicting who will be the ones to sustain fracture is a difficult and imprecise clinical task. The clinical, laboratory, and radiologic methods available for this purpose are reviewed. A rational approach to this problem in today's setting is outlined.

Entities:  

Mesh:

Year:  1987        PMID: 3799741     DOI: 10.1016/0002-9378(87)90192-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Height loss predicts subsequent hip fracture in men and women of the Framingham Study.

Authors:  Marian T Hannan; Kerry E Broe; L Adrienne Cupples; Alyssa B Dufour; Margo Rockwell; Douglas P Kiel
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  A critical review of bone mass and the risk of fractures in osteoporosis.

Authors:  P D Ross; J W Davis; J M Vogel; R D Wasnich
Journal:  Calcif Tissue Int       Date:  1990-03       Impact factor: 4.333

3.  LH-RH agonist (buserelin): treatment of endometriosis. Clinical, laparoscopic, endocrine and metabolic evaluation.

Authors:  U Cirkel; K W Schweppe; H Ochs; J P Hanker; H P Schneider
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

4.  Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss.

Authors:  M D Creagh; R G Malia; S M Cooper; A R Smith; S L Duncan; M Greaves
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

5.  Prenatal screening for hepatitis B surface antigen. Is universal screening necessary?

Authors:  B A Morris; L Sabetti
Journal:  Can Fam Physician       Date:  1993-01       Impact factor: 3.275

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.